Publication | Closed Access

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

Translational MedicineOcular DiseaseOphthalmologyExperimental OphthalmologyAge-related DiseasesOcular PathologyMedicine48-Week Results